<code id='4B3C862EEE'></code><style id='4B3C862EEE'></style>
    • <acronym id='4B3C862EEE'></acronym>
      <center id='4B3C862EEE'><center id='4B3C862EEE'><tfoot id='4B3C862EEE'></tfoot></center><abbr id='4B3C862EEE'><dir id='4B3C862EEE'><tfoot id='4B3C862EEE'></tfoot><noframes id='4B3C862EEE'>

    • <optgroup id='4B3C862EEE'><strike id='4B3C862EEE'><sup id='4B3C862EEE'></sup></strike><code id='4B3C862EEE'></code></optgroup>
        1. <b id='4B3C862EEE'><label id='4B3C862EEE'><select id='4B3C862EEE'><dt id='4B3C862EEE'><span id='4B3C862EEE'></span></dt></select></label></b><u id='4B3C862EEE'></u>
          <i id='4B3C862EEE'><strike id='4B3C862EEE'><tt id='4B3C862EEE'><pre id='4B3C862EEE'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:knowledge    Page View:1443
          Photo illustration of a checkbook wrapped with lock and chain – hospital and investment coverage from STAT
          Alex Hogan/STAT

          Hospitals once dove headfirst into venture capital with splashy headlines and attention-grabbing numbers. Now, in an era of flattened margins and exceedingly uncertain returns, many health systems are quietly pulling back.

          NewYork-Presbyterian’s venture firm, once managing roughly $40 million in assets, was essentially dissolved, two former employees said, with leaders punting it from the system’s strategy division to innovation, then from innovation to the investment office — a spokesperson described it as being “integrated” into the broader strategy. PitchBook data show no investments after 2020.

          advertisement

          Advocate Health Enterprises, meanwhile, the venture firm of a 67-hospital system based in Charlotte, N.C., has lost at least six employees within the past year, including its president, from a staff that once included about a dozen people.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more
          Novo acquires Inversago for up to $1 billion
          Novo acquires Inversago for up to $1 billion

          LISELOTTESABROE/Scanpix/AFPviaGettyImagesFreshoffofthenewsthatitsdrugWegovymaynotjusthelppeoplelosew

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          After John Oliver segment, STAT readers share their opioid

          STATWhencomedian JohnOliver tookpharmacompaniestotask onhisHBOshowSundayfortheirmarketingofpowerfuln